Cargando…

The effect of beta-blockers in acute heart failure according to heart rate

BACKGROUND/AIMS: Beta-blockers (BBs) have been shown to improve clinical outcomes in heart failure (HF) patients. We evaluated the prescribing status of BBs in patients with HF with reduced ejection fraction (HFrEF) at discharge according to the presence or not of bradycardia, and its effect on prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun-Jin, Jo, Sang-Ho, Lee, Min-Ho, Seo, Won-Woo, Choi, Jin-Oh, Ryu, Kyu-Hyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273820/ https://www.ncbi.nlm.nih.gov/pubmed/32872744 http://dx.doi.org/10.3904/kjim.2020.270

Ejemplares similares

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
por: Kim, Sung-Hwan, et al.
Publicado: (2018)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

Heart Rate and Cardiovascular Disease: An Alternative to Beta Blockers
por: Liang, Michael, et al.
Publicado: (2009)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
por: Park, Jin Joo, et al.
Publicado: (2019)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
por: Guo, Yong-Fang, et al.
Publicado: (2011)

Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently
por: Oomman, Abraham, et al.
Publicado: (2018)

Post-Exercise Heart Rate Recovery Independently Predicts Clinical Outcome in Patients with Acute Decompensated Heart Failure
por: Youn, Jong-Chan, et al.
Publicado: (2016)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
por: Uhm, Jae‐Sun, et al.
Publicado: (2021)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Renal Dysfunction in Acute Heart Failure
por: Han, Seong Woo, et al.
Publicado: (2011)

The Relationship Between Heart Rate Reserve and Oxygen Uptake Reserve in Heart Failure Patients on Optimized and Non-Optimized Beta-Blocker Therapy
por: Carvalho, Vitor Oliveira, et al.
Publicado: (2008)

KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure
por: Lee, Jeong Hyun, et al.
Publicado: (2020)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients
por: Taneva, Borjanka, et al.
Publicado: (2016)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Using machine learning to uncover heterogeneity of beta blocker response in heart failure
por: Tison, Geoffrey H.
Publicado: (2022)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
por: Steg, Ph. Gabriel, et al.
Publicado: (2012)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
por: Habel, Nicole, et al.
Publicado: (2023)

Myocardial strain to identify benefit from beta‐blockers in patients with heart failure with reduced ejection fraction
por: Park, Chan Soon, et al.
Publicado: (2022)

Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Self-Reported and Actual Beta-Blocker Prescribing for Heart Failure Patients: Physician Predictors
por: Sinha, Sanjai, et al.
Publicado: (2009)

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
por: Kotecha, Dipak, et al.
Publicado: (2013)

Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2014)

Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers
por: Cattadori, Gaia, et al.
Publicado: (2020)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

A case of heart failure complicated with double ventricular response triggered by beta blocker
por: Kazama, Shingo, et al.
Publicado: (2020)

Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
por: Perry, Andrew S., et al.
Publicado: (2023)

Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry
por: Yazdi, Maryam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gr1hpir76lp3bs5tijku9r7beg